Protein 4.1 tumor suppressors: Getting a FERM grip on growth regulation

Journal of Cell Science

Volumn 115, Issue 21, 2002, Pages 3991-4000

  Sun, Chun Xiao ^a   Robb, Victoria A ^a   Gutmann, David H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

DAL 1; Merlin; Schwannomin; Tumor suppressor

Indexed keywords

ACTIN; CELL SURFACE PROTEIN; ERYTHROCYTE BAND 4.1 PROTEIN; EZRIN; HERMES ANTIGEN; MERLIN; MOESIN; RADIXIN; TUMOR SUPPRESSOR PROTEIN; CYTOSKELETON PROTEIN; MEMBRANE PROTEIN; NEURONAL MEMBRANE CYTOSKELETAL PROTEIN 4.1; NEUROPEPTIDE;

BRAIN CANCER; BREAST CANCER; CANCER INHIBITION; CANCER SUSCEPTIBILITY; CELL MEMBRANE; CELL NUCLEUS; CYTOSKELETON; EXPERIMENTAL MODEL; GROWTH INHIBITION; GROWTH REGULATION; HUMAN; LUNG CANCER; NEUROFIBROMATOSIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; ANIMAL; CELL TRANSFORMATION; CYTOLOGY; EUKARYOTIC CELL; GENETICS; METABOLISM; PROTEIN TERTIARY STRUCTURE;

FALCO COLUMBARIUS;

ANIMALS; ANTIGENS, CD44; CELL TRANSFORMATION, NEOPLASTIC; CYTOSKELETAL PROTEINS; EUKARYOTIC CELLS; HUMANS; MEMBRANE PROTEINS; NEUROFIBROMIN 2; NEUROPEPTIDES; PROTEIN STRUCTURE, TERTIARY; TUMOR SUPPRESSOR PROTEINS;

EID: 0036860545     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.00094     Document Type: Review

References (104)

1. Bashour, A. M., Meng, J. J., Ip, W., MacCollin, M. and Ratner, N. (2002). The neurofibromatosis type 2 gene product, merlin, reverses the F-actin cytoskeletal defects in primary human schwannoma cells. Mol. Cell. Biol. 22, 1150-1157.
2. Bianchi, A. B., Hara, T., Ramesh, V., Gao, J., Klein-Szanto, A. J., Morin, F., Menon, A. G., Trofatter, J. A., Gusella, J. F. and Seizinger, B. R. (1994). Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human turnout types. Nat. Genet. 6, 185-192.
3. Bourguignon, L. Y., Zhu, H., Shao, L. and Chen, Y. W. (2000). CD44 interaction with tiam1 promotes Rac1 signaling and hyaluronic acid-mediated breast tumor cell migration. J. Biol. Chem. 275, 1829-1838.
4. Bourguignon, L. Y., Zhu, H., Zhou, B., Diedrich, F., Singleton, P. A. and Hung, M. C. (2001). Hyaluronan promotes CD44v3-Vav2 interaction with Grb2-p185(HER2) and induces Rac1 and Ras signaling during ovarian tumor cell migration and growth. J. Biol. Chem. 276, 48679-48692.
5. Brault, E., Gautreau, A., Lamarine, M., Callebaut, I., Thomas, G. and Goutebroze, L. (2001). Normal membrane localization and actin association of the NF2 tumor suppressor protein are dependent on folding of its N-terminal domain. J Cell Sci. 114, 1901-1912.
6. Bretscher, A. (1999). Regulation of cortical structure by the ezrin-radixinmoesin protein family. Curr. Opin. Cell Biol. 11, 109-116.
7. Burridge, K. and Connell, L. (1983). Talin: a cytoskeletal component concentrated in adhesion plaques and other sites of actin-membrane interaction. Cell Motil. 3, 405-417.
8. Chin, L.-S., Raynor, M. C., Wei, X., Chen, H.-Q. and Li, L. (2001). Hrs interacts with sorting nexin 1 and regulates degradation of epidermal growth factor receptor. J. Biol. Chem. 276, 7069-7078.
9. Chishti, A. H., Kim, A. C., Marfatia, S. M., Lutchman, M., Hanspal, M., Jindal, H., Liu, S. C., Low, P. S., Rouleau, G. A., Mohandas, N. et al. (1998). The FERM domain: a unique module involved in the linkage of cytoplasmic proteins to the membrane. Trends Biochem. Sci. 23, 281-282.
10. Clague, M. J. and Urbe, S. (2001). The interface of receptor trafficking and signaling. J. Cell Sci. 114, 3075-3081.
11. Correas, I. and Avila, J. (1988). Erythrocyte protein 4.1 associates with tubulin. Biochem. J. 255, 217-221.
12. Cuppen, E., Wijers, M., Schepens, J., Fransen, J., Wieringa, B. and Hendriks, W. A. (1999). FERM domain governs apical confinement of PTP-BL in epithelial cells. J. Cell Sci. 112, 3299-3308.
13. Edwards, S. D. and Keep, N. H. (2001). The 2.7 A crystal structure of the activated FERM domain of moesin: an analysis of structural changes on activation. Biochemistry 40, 7061-7068.
14. Evans, D. G., Sainio, M. and Baser, M. E. (2000). Neurofibromatosis type 2. J. Med. Genet. 37, 897-904.
15. Fernandez-Valle, C., Tang, Y., Ricard, J., Rodenas-Ruano, A., Taylor, A., Hackler, E., Biggerstaff, J. and Iacovelli, J. (2002). Paxillin binds schwannomin and regulates its density-dependent localization and effect on cell morphology. Nat. Genet. 31, 354-362.
16. Gary, R. and Bretscher, A. (1995). Ezrin self-association involves binding of an N-terminal domain to a normally masked carboxyl terminal domain that includes the F-actin binding site. Mol. Biol. Cell 6, 1061-1075.
17. Gimm, J. A., An, X., Nunomura, W. and Mohandas, N. (2002). Functional characterization of spectrin-actin-binding domains in 4.1 family of proteins. Biochemistry 41, 7275-7282.
18. Giovannini, M., Robanus-Maandag, E., van der Valk, M., Niwa-Kawakita, M., Abramowski, V, Goutebroze, L., Woodruff, J. M., Berns, A. and Thomas, G. (2000). Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2. Genes Dev. 14, 1617-1630.
19. Gonzalez-Agosti, C., Wiederhold, T., Herndon, M. E., Gusella, J. and Ramesh, V. (1999). Interdomain interaction of merlin isoforms and its influence on intermolecular binding to NHE-RF. J. Biol. Chem. 274, 34438-34442.
20. Goutebroze, L., Brault, E., Muchardt, C., Camonis, J. and Thomas, G. (2000). Cloning and characterization of SCHIP-1 , a novel protein interacting specifically with spliced isoforms and naturally occurring mutant NF2 proteins. Mol. Cell. Biol. 20, 1699-1712.
21. Gu, M. X., York, J. D., Warshawsky, I. and Majerus, P. W. (1991). Identification, cloning, and expression of a cytosolic megakaryocyte protein-tyrosine-phosphatase with sequence homology to cytoskeletal protein 4.1. Proc. Natl. Acad. Sci. USA. 88, 5867-5871.
22. Gutmann, D. H., Giordano, M. J., Fishback, A. S. and Guha, A. (1997). Loss of merlin expression in sporadic meningiomas, ependymomas and schwannomas. Neurology 49, 267-270.
23. Gutmann, D. H., Haipek, C. A. and Lu, K. H. (1999a). Neurofibromatosis 2 tumor suppressor protein, merlin, forms two functionally important intramolecular associations. J. Neurosci. Res. 58, 706-716.
24. Gutmann, D. H., Sherman, L., Seftor, L., Haipek, C., Lu, K. H. and Hendrix, M. (1999b). Increased expression of the NF2 tumor suppressor gene product, merlin, impairs cell motility, adhesion and spreading. Hum. Mol. Genet. 8, 267-275.
25. Gutmann, D. H., Donahoe, J., Perry, A., Lemke, N., Gorse, K., Kittiniyom, K., Rempel, S. A., Gutierrez, J. A. and Newsham, I. F. (2000). Loss of DAL-1, a protein 4.1 related tumor suppressor, is an important early event in the pathogenesis of meningiomas. Hum. Mol. Genet. 12, 1495-1500.
26. Gutmann, D. H., Hirbe, A. C. and Haipek, C. A. (2001a). Functional analysis of neurofibromatosis 2 (NF2) missense mutations. Hum. Mol. Genet. 10, 1519-1529.
27. Gutmann, D. H., Haipek, C. A., Burke, S. P., Sun, C. X., Scoles, D. R. and Pulst, S. M. (2001b). The NF2 interactor, hepatocyte growth factor-regulated tyrosine kinase substrate (HRS), associates with merlin in the 'open' conformation and suppresses cell growth and motility. Hum. Mol. Genet. 10, 825-834.
28. Gutmann, D. H., Hirbe, A. C., Huang, Z. Y. and Haipek, C. A. (2001c). The protein 4.1 tumor suppressor, DAL-1, impairs cell motility, but regulates proliferation in a cell-type-specific fashion. Neurobiol. Dis. 8, 266-278.
29. Hamada, K., Shimizu, T., Matsui, T., Tsukita, S. and Hakoshima, T. (2000). Structural basis of the membrane-targeting and unmasking mechanisms of the radixin FERM domain. EMBO J. 19, 4449-4462.
30. Hayakawa, A. and Kitamura, N. (2000). Early endosomal localization of hrs; requires a sequence within the proline- and glutamine-rich region but not the FYVE finger. J. Biol. Chem. 275, 29636-29642.
31. Hemming, N. J., Anstee, D. J., Mawby, W. J., Reid, M. E. and Tanner, M. J. (1994). Localization of the protein 4.1-binding site on human erythrocyte glycophorins C and D. Biochem. J. 299, 191-196.
32. Hirao, M., Sato, N., Kondo, T., Yonemura, S., Monden, M., Sasaki, T., Takai, Y., Tsukita, S. and Tsukita, S. (1996). Regulation mechanism of ERM (ezrin/radixin/moesin) protein/plasma membrane association: possible involvement of phosphatidylinositol turnover and Rho-dependent signaling pathway. J. Cell Biol. 135, 37-51.
33. Holzwarth, G., Yu, J. and Steck, T. L. (1976). Heterogeneity in the conformation of different protein fractions from the human erythrocyte membrane. J. Supramol. Struct. 4, 161-168.
34. Hou, C. L., Tang, C. C., Roffler, S. R. and Tang, T. K. (2000). Protein 4.1R binding to eIF3-p44 suggests an interaction between the cytoskeletal network and the translational apparatus. Blood 96, 747-753.
35. Huang, S., Lichtenauer, U. D., Pack, S., Wang, C., Kim, A. C., Lutchman, M., Koch, C. A., Torres-Cruz, J., Huang, S. C., Benz, E. J. Jr et al. (2001). Reassignment of the EPB4.1 gene to 1p36 and assessment of its involvement in neuroblastomas. Eur J. Clin. Invest. 31, 907-914.
36. Hung, L. Y., Tang, C. C. and Tang, T. K. (2000). Protein 4.1R-135 interacts with a novel centrosomal protein (CPAP) which is associated with the gamma-tubulin complex. Mol. Cell. Biol. 20, 7813-7825.
37. Ikeda, K., Saeki, Y., Gonzalez-Agosti, C., Ramesh, V. and Chiocca, E. A. (1999). Inhibition of NF2-negative and NF2-positive primary human meningioma cell proliferation by overexpression of merlin due to vector-mediated gene transfer. Neurosurgery 91, 85-92.
38. Jannatipour, M., Dion, P., Khan, S., Jindal, H., Fan, X., Laganiere, J., Chishti, A. H. and Rouleau, G. A. (2001). Schwannomin isoform-1 interacts with syntenin via PDZ domains. J. Biol. Chem. 276, 33093-33100.
39. Kalamarides, M., Niwa-Kawakita, M., Leblois, H., Abramowski, V., Perricaudet, M., Janin, A., Thomas, G., Gutmann, D. H. and Giovannini, M. (2002). Nf2 gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mouse. Genes Dev. 16, 1060-1065.
40. Kang, B. S., Cooper, D. R., Devedjiev, Y., Derewenda, U. and Derewenda, Z. S. (2002). The structure of the FERM domain of merlin, the neurofibromatosis type 2 gene product. Acta Crystallogr D Biol. Crystallogr 58, 381-391.
41. Kissil, J. L., Johnson, K. C., Eckman, M. S. and Jacks, T. (2002). Merlin Phosphorylation by p2l-activated Kinase 2 and Effects of Phosphorylation on Merlin Localization. J. Biol. Chem. 277, 10394-10399.
42. MacDougall, N., Lad, Y., Wilkie, G. S., Francis-Lang, H., Sullivan, W. and Davis, I. (2001). Merlin, the Drosophila homologue of neurofibromatosis-2, is specifically required in posterior follicle cells for axis formation in the oocyte. Development 128, 665-673.
43. Magendantz, M., Henry, M. D., Lander, A. and Solomon, F. (1995). Interdomain interactions of radixin in vitro. J. Biol. Chem. 270, 25324-25327.
44. Marfatia, S. M., Leu, R. A., Branton, D. and Chishti, A. H. (1995). Identification of the protein 4.1 binding interface on glycophorin C and p55, a homologue of the Drosophila discs-large tumor suppressor protein. J. Biol. Chem. 270, 715-719.
45. Matsui, T., Maeda, M., Doi, Y., Yonemura, S., Amano, M., Kaibuchi, K., Tsukita, S. and Tsukita, S. (1998). Rho-kinase phosphorylates COOH-terminal threonines of ezrin/radixin/moesin (ERM) proteins and regulates their head-to-tail association. J. Cell Biol. 140, 647-657.
46. Matsui, T., Yonemura, S., Tsukita, S. and Tsukita, S. (1999). Activation of ERM proteins in vivo by Rho involves phosphatidyl-inositol 4-phosphate 5-kinase and not ROCK kinases. Curr. Biol. 9, 1259-1262.
47. Mattagajasingh, S. N., Huang, S. C., Hartenstein, J. S., Snyder, M., Marchesi, V. T. and Benz, E. J. (1999). A nonerythroid isoform of protein 4.1R interacts with the nuclear mitotic apparatus (NuMA) protein. J Cell Biol. 145, 29-43.
48. McCartney, B. M., Kulikauskas, R. M., LaJeunesse, D. R. and Fehon, R. G. (2000). The neurofibromatosis-2 homologue, Merlin, and the tumor suppressor expanded function together in Drosophila to regulate cell proliferation and differentiation. Development 127, 1315-1324.
49. McClatchey, A. I., Saotome, I., Ramesh, V., Gusella, J. F. and Jacks, T. (1997). The Nf2 tumor suppressor gene product is essential for extraembryonic development immediately prior to gastrulation. Genes Dev. 11, 1253-1265.
50. McClatchey, A. I., Saotome, I., Mercer, K., Crowley, D., Gusella, J. F., Bronson, R. T. and Jacks, T. (1998). Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors. Genes Dev. 12, 1121-1133.
51. Meng, J. J., Lowrie, D. J., Sun, H., Dorsey, E., Pelton, P. D., Bashour, A. M., Groden, J., Ratner, N. and Ip, W. (2000). Interaction between two isoforms of the NF2 tumor suppressor protein, merlin, and between merlin and ezrin, suggests modulation of ERM proteins by merlin. J. Neurosci. Res. 62, 491-502.
52. Merel, P., Hoang-Xuan, K., Sanson, M., Moreau-Aubry, A., Bijisma, E. K., Lazaro, C., Moisan, J. P., Resche, F., Nishisho, I., Estivill, X. et al. (1995). Predominant occurrence of somatic mutation sof the NF2 gene in meningiomas and schwannomas. Genes Chromosomes Cancer 13, 211-216.
53. Miura, S., Takeshita, T., Asao, H., Kimura, Y., Murata, K., Sasaki, Y., Hanai, J. I., Beppu, H., Tsukazaki, T., Wrana, J. L. et al. (2000). Hgs (Hrs), a FYVE domain protein, is involved in Smad signaling through cooperation with SARA. Mol. Cell. Biol. 20, 9346-9355.
54. Morrison, H., Sherman, L. S., Legg, J., Banine, F., Isacke, C., Haipek, C. A., Gutmann, D. H., Ponta, H. and Herrlich, P. (2001). The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44. Genes Dev. 15, 968-980.
55. + exchange, is a common interactor for merlin and ERM (MERM) proteins. J. Biol. Chem. 273, 1273-1276.
56. Muslin, A. J. and Xing, H. (2000). 14-3-3 proteins: regulation of subcellular localization by molecular interference. Cell Signal. 12, 703-709.
57. Nguyen, R., Reczek, D. and Bretscher, A. (2001). Hierarchy of merlin and ezrin N- and carboxyl terminal domain interactions in homo- and heterotypic associations and their relationship to binding of scaffolding proteins EBP50 and E3KARP. J. Biol. Chem. 276, 7621-7629.
58. Nunomura, W., Takakuwa, Y., Tokimitsu, R., Krauss, S. W., Kawashima, M. and Mohandas, N. (1997). Regulation of CD44-protein 4.1 interaction by Ca2+ and calmodulin. Implications for modulation of CD44-ankyrin interaction. J. Biol. Chem. 272, 30322-30328.
59. Obremski, V. J., Hall, A. M. and Fernandez-Valle, C. (1998). Merlin, the neurofibromatosis type 2 gene product, and beta1 integrin associate in isolated and differentiating Schwann cells. J. Neurobiol. 37, 487-501.
60. Ohanian, V., Wolfe, L. C., John, K. M., Pinder, J. C., Lux, S. E. and Gratzer, W. B. (1984). Analysis of the ternary interaction of the red cell membrane skeletal proteins spectrin, actin, and 4.1. Biochemistry 23, 4416-4420.
61. Oshira, N., Fukata, Y. and Kaibuchi, K. (1998). Phosphorylation of moesin by Rho-associated kinase (Rho-kinase) plays a crucial role in the formation of microviulli-like structures. J. Biol. Chem. 273, 34663-34666.
62. Parra, M., Gascard, P., Walensky, L. D., Gimm, J. A., Blackshaw, S., Chan, N., Takakuwa, Y., Berger, T., Lee, G., Chasis, J. A. et al. (2000). Molecular and functional characterization of protein 4.1B, a novel member of the protein 4.1 family with high level, focal expression in brain. J. Biol. Chem. 275, 3247-3255.
63. Pasternack, G. R., Anderson, R. A., Leto, T. L. and Marchesi, V. T. (1985). Interactions between protein 4.1 and band 3. An alternative binding site for an element of the membrane skeleton. J. Biol. Chem. 260, 3676-3683.
64. Peach, R. J., Hollenbaugh, D., Stamenkovic, I. and Aruffo, A. (1993). Identification of hyaluronic acid binding sites in the extracellular domain of CD44. J. Cell Biol. 122, 257-264.
65. Pearson, M. A., Reczek, D., Bretscher, A. and Karplus, P, A. (2000). Structure of the ERM protein moesin reveals the FERM domain fold masked by an extended actin binding tail domain. Cell 101, 259-270.
66. Pelton, P. D., Sherman, L. S., Rizvi, T. A., Marchionni, M. A., Wood, P., Friedman, R. A. and Ratner, N. (1998). Ruffling membrane, stress fiber, cell spreading and proliferation abnormalities in human Schwannoma cells. Oncogene 17, 2195-2209.
67. Perry, A., Cai, D. X., Scheithauer, B. W., Swanson, P. E., Lohse, C. M., Newsham, I. F., Weaver, A. and Gutmann, D. H. (2000). Merlin, DAL-1, and progesterone receptor expression in clinicopathologic subsets of meningioma: a correlative immunohistochemical study of 175 cases. J. Neuropathol. Exp. Neurol. 59, 872-879.
68. Peters, L. L., Weier, H. U., Walensky, L. D., Snyder, S. H., Parra, M., Mohandas, N. and Conboy, J. G. (1998). Four paralogous protein 4.1 genes map to distinct chromosomes in mouse and human. Genomics 54, 348-350.
69. Raiborg, C., Bremnes, B., Mehlum, A., Gillooly, D. J., D'Arrigo, A., Stang, E. and Stenmark, H. (2001). FYVE and coiled-coil domains determine the specific localisation of Hrs to early endosomes. J. Cell Sci. 114, 2255-2263.
70. Reczek, D. and Bretscher, A. (1998). The carboxyl-terminal region of EBP50 binds to a site in the amino-terminal domain of ezrin that is masked in the dormant molecule. J. Biol. Chem. 273, 18452-18458.
71. Reczek, D., Berryman, M. and Bretscher, A. (1997). Identification of EBP50: A PDZ-containing phosphoprotein that associates with members of the ezrin-radixin-moesin family. J. Cell Biol. 139, 169-179.
72. Reed, N. and Gutmann, D. H. (2001). Tumorigenesis in neurofibromatosis: new insights and potential therapies. Trends Mol. Med. 7, 157-162.
73. Rouleau, G. A., Merel, P., Lutchman, M., Sanson, M., Zucman, J., Marineau, C., Hoang-Xuan, K., Demczuk, M., Desmaze, C. and Plougastel, B. (1993). Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 63, 515-521.
74. Ruttledge, M. H., Sarrazin, J., Rangaratnam, S., Phelan, C. M., Twist, E., Merel, P., Delattre, O., Thomas, G., Nordenskjöld, M. et al. (1994). Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nat. Genet. 6, 180-184.
75. Sainio, M., Zhao, F., Heiska, L., Turunen, O., den Bakker, M., Zwarthoff, E., Lutchman, M., Rouleau, G. A., Jaaskelainen, J., Vaheri, A. and Carpen, O. (1997). Neurofibromatosis 2 tumor suppressor protein colocalizes with ezrin and CD44 and associates with actin-containing cytoskeleton. J. Cell Sci. 110, 2249-2260.
76. Scherer, S. S. and Gutmann, D. H. (1996). Expression of the neurofibromatosis 2 tumor suppressor gene product, merlin, in Schwann cells. J. Neurosci. Res. 46, 595-605.
77. Scherer, S. S., Xu, T., Crino, P., Arroyo, E. J. and Gutmann, D. H. (2001). Ezrin, radixin, and moesin are components of Schwarm cell microvilli. J. Neurosci. Res. 65, 150-164.
78. Scoles, D. R., Huynh, D. P., Morcos, P. A., Coulsell, E. R., Robinson, N. G. G., Tamanoi, F. and Pulst, S. M. (1998). Neurofibromatosis 2 tumor suppressor schwannomin interacts with βII-spectrin. Nat. Genet. 18, 354-359.
79. Scoles, D. R., Huynh, D. P., Chen, M. S., Burke, S. P., Gutmann, D. H. and Pulst, S.-M. (2000). The neurofibromatosis 2 tumor suppressor protein interacts with hepatocyte growth factor-regulated tyrosine kinase substrate. Hum. Mol. Genet. 9, 1567-1574.
80. Shaw, R. J., McClatchey, A. I. and Jacks, T. (1998). Regulation of the neurofibromatosis type 2 tumor suppressor protein, merlin, by adhesion and growth arrest stimuli. J. Biol. Chem. 273, 7757-7764.
81. Shaw, R. J., Paez, J. G., Curto, M., Yaktine, A., Pruitt, W. M., Saotome, I., O'Bryan, J. P., Gupta, V., Ratner, N., Der, C. J. et al. (2001). The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling. Dev. Cell 1, 63-72.
82. Shen, L., Liang, F., Walensky, L. D. and Huagnir, R. L. (2000). Regulation of AMPA receptor GluR1 subunit surface expression by a 4.1N-linked actin cytoskeletal association. J. Neurosci. 20, 7932-7940.
83. Sherman, L. S. and Gutmann, D. H. (2001). Merlin: hanging tumor suppression on the Rac. Trends Cell Biol. 11, 442-444.
84. Sherman, L., Xu, H. M., Geist, R. T., Saporito-Irwin, S., Howells, N., Ponta, H., Herrlich, P. and Gutmann, D. H. (1997). Interdomain binding mediates tumor growth suppression by the NF2 gene product. Oncogene 15, 2505-2509.
85. Shi, Z. T., Afzal, V., Coller, B., Patel, D., Chasis, J. A., Parra, M., Lee, G., Paszty, C., Stevens, M., Walensky, L. et al. (1999). Protein 4.1R-deficient mice are viable but have erythroid membrane skeleton abnormalities. J. Clin. Invest. 103, 331-340.
86. Shimizu, T., Nagamuchi, Y. Tani, M., Kimura, K., Shiroishi, T., Wakana, S. and Yokota, J. (2000). Molecular cloning of a nove1 NF2/ERM/4.1 superfamily gene, ehm2, that is expressed in high-metastatic K1735 murine melanoma cells. Genomics 65, 113-120.
87. Shimizu, T., Seto, A., Maita, N., Hamada, K., Tsukita, S., Tsukita, S. and Hakoshima, T. (2002). Structural basis for neurofibromatosis type 2: Crystal structure of the merlin FERM domain. J. Biol. Chem. 277, 10332-10336.
88. Takeuchi, K., Kawashima, A., Nagafuchi, A. and Tsukita, S. (1994). Structural diversity of band 4.1 superfamily members. J. Cell Sci. 107, 1921-1928.
89. Tanaka, T., Kadowaki, K., Lazarides, E. and Sobue, K. (1991). Ca2(+)-dependent regulation of the spectrin/actin interaction by calmodulin and protein 4.1. J. Biol. Chem. 266, 1134-1140.
90. Tang, C. C. and Tang, T. K. (1998). The 30-kD domain of Protein 4.1 mediates its binding to the carboxyl terminus of pIC1n, a protein involved in cellular volume regulation. Blood 92, 1442-1447.
91. Tchernia, G., Mohandas, N. and Shohet, S. B. (1981). Deficiency of skeletal membrane protein band 4.1 in homozygous hereditary elliptocytosis. Implications for erythrocyte membrane stability. J. Clin. Invest. 68, 454-460.
92. Tran, Y. K., Bogler, O., Gorse, K. M., Wieland, I., Green, M. R. and Newsham, I. F. (1999). A Novel Member of the NF2/ERM/4.1 Superfamily with Growth Suppressing Properties in Lung Cancer. Cancer Res. 59, 35-43.
93. Trofatter, J. A., MacCollin, M. M., Rutter, J. L., Murrell, J. R., Duyao, M. P., Parry, D. M., Eldridge, R., Kley, N., Menon, A. G., Pulaski, K. et al. (1993). A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 72, 1-20.
94. Twist, E. C., Ruttledge, M. H., Rousseau, M., Sanson, M., Papi, L., Merel, P., Delattre, O., Thomas, G. and Rouleau, G. (1994). The neurofibromatosis type 2 gene in inactivated in schwannomas. Hum. Mol. Genet. 3, 147-151.
95. Uchida, Y., Ogata, M., Mori, Y., Oh-hora, M., Hatano, N. and Hamaoka, T. (2002). Localization of PTP-FERM in nerve processes through its FERM domain. Biochem. Biophys. Res. Commun. 292, 13-19.
96. Urbe, S., Mills, I. G., Stenmark, H., Kitamura, N. and Clague, M. J. (2000). Endosomal localization and receptor dynamics determine tyrosine phosphorylation of hepatocyte growth factor-regulated tyrosine kinase substrate. Mol. Cell. Biol. 20, 7685-7692.
97. Voltz, J. W., Weinman, E. J. and Shenolikar, S. (2001). Expanding the role of NHERF, a PDZ-domain containing protein adapter, to growth regulation. Oncogene 20, 6309-6314.
98. Walensky, L. D., Gascard, P., Fields, M. E., Blackshaw, S., Conboy, J. G., Mohandas, N. and Snyder, S. H. (1998). The 13-kD FK506 binding protein, FKBP13, interacts with a novel homologue of the erythrocyte membrane cytoskeletal protein 4.1. J. Cell Biol. 6, 141, 143-153.
99. Xiao, G. H., Beeser, A., Chernoff, J. and Testa, J. R. (2002). p2l-activated kinase links Rac/Cdc42 signaling to merlin. J. Biol. Chem. 277, 883-886.
100. Xu, H. M. and Gutmann, D. H. (1998). Merlin differentially associates with the microtubule and actin cytoskeleton. J. Neurosci. Res. 51, 403-415.
101. Ye, K., Compton, D. A., Lai, M. M., Walensky, L. D. and Snyder, S. H. (1999). Protein 4.1N binding to nuclear mitotic apparatus protein in PC12 cells mediates the antiproliferative actions of nerve growth factor. J Neurosci. 19, 10747-10756.
102. Ye, K., Hurt, J., Wu, F. Y., Fang, M., Luo, H. R., Hong, J. J., Blacksaw, S., Ferris, C. D. and Snyder, S. H. (2000). PIKE: a nuclear GTPase that enhances PI3Kinase activity and is regulated by Protein 4.1N. Cell 103, 919-930.
103. Yu, T., Robb, V. A., Singh, V., Gutmann, D. H. and Newsham, I. F. (2002). The 4.1/ezrin/radixin/moesin domain of the DAL-1/Protein 4.1B tumor suppressor interacts with 14-3-3 proteins. Biochem. J. 365, 783-789.
104. + exchanger NHE3 and the cytoskeletal protein ezrin. J. Biol. Chem. 273, 25856-25863.